Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Embody
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxEmbody
Shoppers comparing low headline prices, who should confirm the actual charge at checkout given the company's own pages disagree.
Visit EmbodyThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 59. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Embody still earns a C — Shoppers comparing low headline prices, who should confirm the actual charge at checkout given the company's own pages disagree.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Embody |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 59/100 |
| Semaglutide / mo | $99/mo | Not disclosed |
| Tirzepatide / mo | $149/mo | Not disclosed |
| Semaglutide / yr (modeled) | $1,188 | — |
| Tirzepatide / yr (modeled) | $1,788 | — |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #221 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Embody
59/100Where the value is
- Flat pricing stated not to rise with dose or across months on the same plan
- No membership fee and no long-term contract — cancel anytime
- Four named compounding pharmacies across four different states, reducing single-facility risk
The tradeoffs
- The company's own pages quote different prices for the same product — $79/$129 on the main domain vs. $69/$119 (crossed out from a much higher $299/$349) on its paid-traffic landing pages — with no way from the page content alone to know which a given customer will actually be charged
- The $299/$349 'original' prices used as strikethrough anchors on the funnel pages are not explained or substantiated anywhere on the main site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.